[PDF][PDF] Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis

…, E Mansour, RG Ulaf, AF Bernardes, TA Nunes… - Cell metabolism, 2020 - cell.com
COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals
with uncontrolled glucose levels are more prone to develop the severe form of COVID-…

[HTML][HTML] Safety and outcomes associated with the pharmacological inhibition of the kinin–kallikrein system in severe COVID-19

…, RG Ulaf, LC Ribeiro, AF Bernardes, TA Nunes… - Viruses, 2021 - mdpi.com
Background: Coronavirus disease 19 (COVID-19) can develop into a severe respiratory
syndrome that results in up to 40% mortality. Acute lung inflammatory edema is a major …

[HTML][HTML] Plasma angiotensin II is increased in critical coronavirus disease 2019

…, RG Ulaf, AF Bernardes, TA Nunes… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-converting
enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested that …

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19

…, MS Barbosa, I Santos, AC Palma, TA Nunes… - Blood …, 2022 - ashpublications.org
Coagulation activation is a prominent feature of severe acute respiratory syndrome
coronavirus 2 (COVID-19) infection. Activation of the contact system and intrinsic pathway has …

SARS-CoV-2 uses CD4 to infect T helper lymphocytes

…, E Mansour, RG Ulaf, AF Bernardes, TA Nunes… - 2020 - pesquisa.bvsalud.org
… Bernardes; Thyago A. Nunes; Luciana C. Ribeiro; Marcus V. Agrela; Maria Luiza Moretti;
Lucas I. … Nunes; Department of Internal Medicine, School of Medical Sciences, University …

[HTML][HTML] Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized …

…, EP Araujo, AF Bernardes, RG Ulaf, TA Nunes… - Trials, 2021 - Springer
Background SARS-CoV-2, the virus that causes COVID-19, enters the cells through a mechanism
dependent on its binding to angiotensin-converting enzyme 2 (ACE2), a protein highly …

[HTML][HTML] Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma

LC Ribeiro, BD Benites, RG Ulaf, TA Nunes… - Allergy, Asthma & …, 2021 - Springer
Background Common variable immunodeficiency is the most prevalent symptomatic
primary immunodeficiency in adults. Affected patients fail to mount an appropriate humoral …

Pharmacological inhibition of the kinin-kallikrein system in severe COVID-19–A proof-of-concept study

…, RG Ulaf, LC Ribeiro, AF Bernardes, TA Nunes… - MedRxiv, 2020 - medrxiv.org
Coronavirus disease-19 (COVID-19) can develop into a severe respiratory syndrome that
results in up to 40% mortality. Acute lung inflammatory edema is a major pathological finding …

[HTML][HTML] Circulating levels of Ang/Tie2 and VEGF-a pathway mediators are associated with clinical severity, endothelial barrier disruption and coagulation activation in …

…, MS Barbosa, SC Huber, AC Palma, TA Nunes… - Blood, 2021 - Elsevier
Background: the pathogenesis of severe COVID-19 involves the deregulated activation of
different compartments of immunothrombosis, which are otherwise important for pathogen …

SARS-CoV-2 uses CD4 to infect T helper lymphocytes

…, E Mansour, RG Ulaf, AF Bernardes, TA Nunes… - Elife, 2023 - elifesciences.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent of a major
global outbreak of respiratory tract disease known as Coronavirus Disease 2019 (COVID-19)…